Publications

Found 14 results
Author Title [ Type(Asc)] Year
Filters: Author is Vredenburg, Vance T  [Clear All Filters]
Miscellaneous
Vredenburg VT, Briggs CJ, Harris RN.  2011.  Host-pathogen dynamics of amphibian chytridiomycosis: the role of the skin microbiome in health and disease. Fungal diseases: an emerging challenge to human, animal, and plant health. :342–355.
Journal Article
Woodhams DC, Geiger CC, Reinert LK, Rollins-Smith LA, Lam B, Harris RN, Briggs CJ, Vredenburg VT, Voyles J.  2012.  Treatment of amphibians infected with chytrid fungus: learning from failed trials with itraconazole, antimicrobial peptides, bacteria, and heat therapy. Diseases of aquatic organisms. 98:11–25.
Woodhams DC, Vredenburg VT, Simon M-A, Billheimer D, Shakhtour B, Shyr Y, Briggs CJ, Rollins-Smith LA, Harris RN.  2007.  Symbiotic bacteria contribute to innate immune defenses of the threatened mountain yellow-legged frog, Rana muscosa. Biological conservation. 138:390–398.
Harris RN, Brucker RM, Walke JB, Becker MH, Schwantes CR, Flaherty DC, Lam BA, Woodhams DC, Briggs CJ, Vredenburg VT et al..  2009.  Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus. The ISME journal. 3:818–824.
Woodhams DC, Rollins-Smith LA, Reinert LK, Lam BA, Harris RN, Briggs CJ, Vredenburg VT, Patel BT, Caprioli RM, Chaurand P et al..  2019.  Probiotics Modulate a Novel Amphibian Skin Defense Peptide That Is Antifungal and Facilitates Growth of Antifungal Bacteria.. Microb Ecol.
Morgan JAT, Vredenburg VT, Rachowicz LJ, Knapp RA, Stice MJ, Tunstall T, Bingham RE, Parker JM, Longcore JE, Moritz C et al..  2007.  Population genetics of the frog-killing fungus Batrachochytrium dendrobatidis. Proceedings of the National Academy of Sciences. 104:13845–13850.
Voyles J, Vredenburg VT, Tunstall TS, Parker JM, Briggs CJ, Rosenblum EBree.  2012.  Pathophysiology in mountain yellow-legged frogs (Rana muscosa) during a chytridiomycosis outbreak. PLoS One. 7:e35374.
Rachowicz LJ, HERO JEAN, Alford RA, Taylor JW, Morgan JAT, Vredenburg VT, Collins JP, Briggs CJ.  2005.  The novel and endemic pathogen hypotheses: competing explanations for the origin of emerging infectious diseases of wildlife. Conservation Biology. 19:1441–1448.
Knapp RA, Fellers GM, Kleeman PM, Miller DAW, Vredenburg VT, Rosenblum EB, Briggs CJ.  2016.  Large-scale recovery of an endangered amphibian despite ongoing exposure to multiple stressors. Proceedings of the National Academy of Sciences of the United States of America. 113(42):94.
Briggs CJ, Vredenburg VT, Knapp RA, Rachowicz LJ.  2005.  Investigating the population-level effects of chytridiomycosis: an emerging infectious disease of amphibians. Ecology. 86:3149–3159.
Briggs CJ, Knapp RA, Vredenburg VT.  2010.  Enzootic and epizootic dynamics of the chytrid fungal pathogen of amphibians. Proceedings of the National Academy of Sciences. 107:9695–9700.
Rachowicz LJ, Knapp RA, Morgan JAT, Stice MJ, Vredenburg VT, Parker JM, Briggs CJ.  2006.  Emerging infectious disease as a proximate cause of amphibian mass mortality. Ecology. 87:1671–1683.
Vredenburg VT, Knapp RA, Tunstall TS, Briggs CJ.  2010.  Dynamics of an emerging disease drive large-scale amphibian population extinctions. Proceedings of the National Academy of Sciences. 107:9689.
Rollins-Smith LA, Woodhams DC, Reinert LK, Vredenburg VT, Briggs CJ, Nielsen PF, J Conlon M.  2006.  Antimicrobial peptide defenses of the mountain yellow-legged frog (Rana muscosa). Developmental & Comparative Immunology. 30:831–842.